SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-028142
Filing Date
2020-06-03
Accepted
2020-06-03 07:52:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 xene-s3.htm S-3 413365
2 EX-5.1 xene-ex51_6.htm EX-5.1 59699
3 EX-23.1 xene-ex231_7.htm EX-23.1 20313
4 GRAPHIC gwempwlqcb3q000002.jpg GRAPHIC 3807
5 GRAPHIC gwempwlqcb3q000001.jpg GRAPHIC 3807
6 GRAPHIC gxf45mxt1swa000001.jpg GRAPHIC 2469
7 GRAPHIC gafjlmxvthew000002.jpg GRAPHIC 28227
8 GRAPHIC gafjlmxvthew000001.jpg GRAPHIC 14552
  Complete submission text file 0001564590-20-028142.txt   567901
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238896 | Film No.: 20938934
SIC: 2834 Pharmaceutical Preparations